Skip to main content
Equibles

RAYMOND JAMES FINANCIAL INC

Position in SPRO — Spero Therapeutics, Inc.

CIK 720005 ST. PETERSBURG, FL
Back to SPRO Full portfolio

Position in SPRO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,152,968
+$1,144,031 QoQ
Shares Held
521,705
+16827.5% QoQ
Ownership
0.896%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 59 holders
Holding Since
Jun 2025
2 quarters on record
Voting authority Sole 11% Shared 0% None 89%

Common Shares in SPRO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RAYMOND JAMES FINANCIAL INC holds $1,702,332,948 across 201 Biotechnology names. SPRO ranks #99 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 556,876 $276,617,014
2 ALNY
Alnylam Pharmaceuticals, Inc.
 392,799 $118,244,281
3 REGN
Regeneron Pharmaceuticals, Inc.
 172,896 $107,807,571
4 RPRX
Royalty Pharma plc
 1,599,881 $89,705,325
5 INSM
INSMED Inc
 660,601 $70,433,276
6 KRYS
Krystal Biotech, Inc.
 158,675 $58,974,733
7 JAZZ
Jazz Pharmaceuticals plc
 228,645 $55,096,584
8 EXEL
Exelixis, Inc.
 941,571 $51,230,875

All Filings in SPRO

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,152,968 521,705
2025-06-30 $8,937 3,082